Association of decreased estimated glomerular filtration rate with lung cancer risk in the Korean population
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES Inconsistent results are available regarding the association between low estimated glomerular filtration rate (eGFR) and lung cancer risk. We aimed to explore the risk of lung cancer according to eGFR category in the Korean population. METHODS We included 358,293 adults who underwent health checkups between 2009 and 2010, utilizing data from the National Health Insurance Service-National Sample Cohort. Participants were categorized into 3 groups based on their baseline eGFR, as determined using the Chronic Kidney Disease Epidemiology Collaboration equation: group 1 (eGFR ≥90 mL/min/1.73 m<sup>2</sup>), group 2 (eGFR ≥60 to <90 mL/min/1.73 m<sup>2</sup>), and group 3 (eGFR <60 mL/min/1.73 m<sup>2</sup>). Incidences of lung cancer were identified using the corresponding codes from the International Classification of Diseases, 10th revision. Multivariate Cox proportional hazard models were employed to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for lung cancer incidence up to 2019. RESULTS In multivariate analysis, group 2 exhibited a 26% higher risk of developing lung cancer than group 1 (HR, 1.26; 95% CI, 1.19 to 1.35). Furthermore, group 3 demonstrated a 72% elevated risk of lung cancer relative to group 1 (HR, 1.72; 95% CI, 1.58 to 1.89). Among participants with dipstick proteinuria of 2+ or greater, group 3 faced a significantly higher risk of lung cancer than group 1 (HR, 2.93; 95% CI, 1.37 to 6.24). CONCLUSIONS Low eGFR was significantly associated with increased lung cancer risk within the Korean population. A particularly robust association was observed in individuals with severe proteinuria, emphasizing the need for further investigation.
Abstract
OBJECTIVES Inconsistent results are available regarding the association between low estimated glomerular filtration rate (eGFR) and lung cancer risk. We aimed to explore the risk of lung cancer according to eGFR category in the Korean population. METHODS We included 358,293 adults who underwent health checkups between 2009 and 2010, utilizing data from the National Health Insurance Service-National Sample Cohort. Participants were categorized into 3 groups based on their baseline eGFR, as determined using the Chronic Kidney Disease Epidemiology Collaboration equation: group 1 (eGFR ≥90 mL/min/1.73 m<sup>2</sup>), group 2 (eGFR ≥60 to <90 mL/min/1.73 m<sup>2</sup>), and group 3 (eGFR <60 mL/min/1.73 m<sup>2</sup>). Incidences of lung cancer were identified using the corresponding codes from the International Classification of Diseases, 10th revision. Multivariate Cox proportional hazard models were employed to calculate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for lung cancer incidence up to 2019. RESULTS In multivariate analysis, group 2 exhibited a 26% higher risk of developing lung cancer than group 1 (HR, 1.26; 95% CI, 1.19 to 1.35). Furthermore, group 3 demonstrated a 72% elevated risk of lung cancer relative to group 1 (HR, 1.72; 95% CI, 1.58 to 1.89). Among participants with dipstick proteinuria of 2+ or greater, group 3 faced a significantly higher risk of lung cancer than group 1 (HR, 2.93; 95% CI, 1.37 to 6.24). CONCLUSIONS Low eGFR was significantly associated with increased lung cancer risk within the Korean population. A particularly robust association was observed in individuals with severe proteinuria, emphasizing the need for further investigation.
참고문헌 (42)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)[DOI]
- Thai AA, "Lung cancer", Lancet, 398, pp.535~554 (2021)[DOI]
- Wong MC, "Incidence and mortality of lung cancer : global trends and association with socioeconomic status", Sci Rep, 7, pp.14300~ (2017)[DOI]
- Corrales L, "Lung cancer in never smokers : the role of different risk factors other than tobacco smoking", Crit Rev Oncol Hematol, 148, pp.102895~ (2020)[DOI]
- Webster AC, "Chronic kidney disease", Lancet, 389, pp.1238~1252 (2017)[DOI]
- Mok Y, "Albuminuria, kidney function, and cancer risk in the community", Am J Epidemiol, 189, pp.942~950 (2020)[DOI]
- Mok Y, "Kidney function, proteinuria, and cancer incidence : the Korean Heart Study", Am J Kidney Dis, 70, pp.512~521 (2017)[DOI]
- Xu H, "Estimated glomerular filtration rate and the risk of cancer", Clin J Am Soc Nephrol, 14, pp.530~539 (2019)[DOI]
- Lees JS, "Kidney function and cancer risk : an analysis using creatinine and cystatin C in a cohort study", EClinicalMedicine, 38, pp.101030~ (2021)[DOI]
- Jørgensen L, "Association of albuminuria and cancer incidence", J Am Soc Nephrol, 19, pp.992~998 (2008)[DOI]
- Wong G, "Association of CKD and cancer risk in older people", J Am Soc Nephrol, 20, pp.1341~1350 (2009)[DOI]
- Weng PH, "Cancer-specific mortality in chronic kidney disease : longitudinal follow-up of a large cohort", Clin J Am Soc Nephrol, 6, pp.1121~1128 (2011)[DOI]
- Christensson A, "Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years", Int J Cancer, 133, pp.1452~1458 (2013)[DOI]
- Lowrance WT, "CKD and the risk of incident cancer", J Am Soc Nephrol, 25, pp.2327~2334 (2014)[DOI]
- Wong G, "Chronic kidney disease and the risk of cancer : an individual patient data meta-analysis of 32, 057 participants from six prospective studies", BMC Cancer, 16, pp.488~ (2016)[DOI]
- Park S, "Risk of cancer in pre-dialysis chronic kidney disease : a nationwide population-based study with a matched control group", Kidney Res Clin Pract, 38, pp.60~70 (2019)[DOI]
- Miyamoto Y, "Association of chronic kidney disease with total and site-specific cancer incidence in participants of the Japan Public Health Center-based Prospective Study", Nephrol Dial Transplant, 38, pp.1487~1496 (2023)[DOI]
- Liu L, "Association between kidney function and the risk of cancer : results from the China Health and Retirement longitudinal study(CHARLS)", J Cancer, 11, pp.6429~6436 (2020)[DOI]
- Thandra KC, "Epidemiology of lung cancer", Contemp Oncol(Pozn), 25, pp.45~52 (2021)[DOI]
- Berry SD, "Competing risk of death : an important consideration in studies of older adults", J Am Geriatr Soc, 58, pp.783~787 (2010)[DOI]
- Turin TC, "Proteinuria and rate of change in kidney function in a community-based population", J Am Soc Nephrol, 24, pp.1661~1667 (2013)[DOI]
- White SL, "Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community", Am J Kidney Dis, 58, pp.19~28 (2011)[DOI]
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)[DOI]
- International Statistical Classification of Diseases and related health problems: alphabetical index, "World Health Organization", World Health Organization, 38~ (2004)
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)[DOI]
- Levin A, "Kidney Disease : Improving Global Outcomes(KDIGO)CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease", Kidney Int Suppl, 3, pp.1~150 (2013)[DOI]
- "Guidelines for controlling and monitoring the tobacco epidemic" (1998)[URL]
- Durham AL, "The relationship between COPD and lung cancer", Lung Cancer, 90, pp.121~127 (2015)[DOI]
- Qu YL, "Asthma and the risk of lung cancer : a meta-analysis", Oncotarget, 8, pp.11614~11620 (2017)[DOI]
- Yang MS, "Validation of cancer diagnosis based on the National Health Insurance Service Database versus the National Cancer Registry Database in Korea", Cancer Res Treat, 54, pp.352~361 (2022)[DOI]
- Fine JP, "A proportional hazards model for the subdistribution of a competing risk", J Am Stat Assoc, 94, pp.496~509 (1999)[DOI]
- Simerville JA, "Urinalysis : a comprehensive review", Am Fam Physician, 71, pp.1153~1162 (2005)
- Clark WF, "Dipstick proteinuria as a screening strategy to identify rapid renal decline", J Am Soc Nephrol, 22, pp.1729~1736 (2011)[DOI]
- Imai E, "Slower decline of glomerular filtration rate in the Japanese general population : a longitudinal 10-year follow-up study", Hypertens Res, 31, pp.433~441 (2008)[DOI]
- Hu M, "Chronic kidney disease and cancer : inter-relationships and mechanisms", Front Cell Dev Biol, 10, pp.868715~ (2022)[DOI]
- Chen DQ, "Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt", β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease, 2017, pp.12, 505~521
- Pacheco-Pinedo EC, "Wnt and Kras signaling-dark siblings in lung cancer", Oncotarget, 2, pp.569~574 (2011)[DOI]
- Tsay JJ, "Aryl hydrocarbon receptor and lung cancer", Anticancer Res, 33, pp.1247~1256 (2013)
- Wang Z, "How the AHR became important in cancer : the role of chronically active AHR in cancer aggression", Int J Mol Sci, 22, pp.387~ (2020)[DOI]
- Dou L, "Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease", Kidney Int, 93, pp.986~999 (2018)[DOI]
- Garg AX, "Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance", J Am Soc Nephrol, 16, pp.1433~1439 (2005)[DOI]
- Park CK, "Trends and updated statistics of lung cancer in Korea", Tuberc Respir Dis(Seoul), 82, pp.175~177 (2019)[DOI]